Top 10 Evidence-Based Essentials in Family Medicine
-
By
-
Conexiant News Staff
-
May 27, 2026
-
3 min
By
Conexiant News Staff
May 27, 2026
The phase 3 OVERLORD-MS trial compared 2 anti-CD20 therapies in previously untreated adults with newly diagnosed relapsing multiple sclerosis and recent inflammatory disease activity.
July 7, 2026